nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO2B1—Erlotinib—kidney cancer	0.238	0.394	CbGbCtD
Tolbutamide—CYP2C8—Pazopanib—kidney cancer	0.0729	0.121	CbGbCtD
Tolbutamide—KCNJ1—collecting duct of renal tubule—kidney cancer	0.0684	0.376	CbGeAlD
Tolbutamide—CYP2C9—Capecitabine—kidney cancer	0.0531	0.0878	CbGbCtD
Tolbutamide—CYP2C8—Erlotinib—kidney cancer	0.052	0.0862	CbGbCtD
Tolbutamide—CYP2C8—Paclitaxel—kidney cancer	0.0476	0.0789	CbGbCtD
Tolbutamide—CYP2C8—Sorafenib—kidney cancer	0.0423	0.0701	CbGbCtD
Tolbutamide—CYP2C19—Sorafenib—kidney cancer	0.0355	0.0588	CbGbCtD
Tolbutamide—CYP2C9—Paclitaxel—kidney cancer	0.0332	0.055	CbGbCtD
Tolbutamide—KCNJ1—nephron—kidney cancer	0.0304	0.167	CbGeAlD
Tolbutamide—CYP2C9—Sorafenib—kidney cancer	0.0295	0.0489	CbGbCtD
Tolbutamide—CYP2C19—urine—kidney cancer	0.00787	0.0432	CbGeAlD
Tolbutamide—KCNJ1—nephron tubule—kidney cancer	0.00657	0.0361	CbGeAlD
Tolbutamide—CYP2C9—urine—kidney cancer	0.0061	0.0335	CbGeAlD
Tolbutamide—KCNJ1—renal system—kidney cancer	0.00598	0.0328	CbGeAlD
Tolbutamide—KCNJ1—kidney—kidney cancer	0.00578	0.0317	CbGeAlD
Tolbutamide—KCNJ1—cortex of kidney—kidney cancer	0.00563	0.0309	CbGeAlD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Vinblastine—kidney cancer	0.00515	0.0336	CcSEcCtD
Tolbutamide—SLC22A6—nephron tubule—kidney cancer	0.00422	0.0232	CbGeAlD
Tolbutamide—Eruption—Dactinomycin—kidney cancer	0.00383	0.025	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Vincristine—kidney cancer	0.00362	0.0237	CcSEcCtD
Tolbutamide—SLC22A6—cortex of kidney—kidney cancer	0.00361	0.0198	CbGeAlD
Tolbutamide—SLC15A1—nephron tubule—kidney cancer	0.00351	0.0193	CbGeAlD
Tolbutamide—ABCC8—renal system—kidney cancer	0.00334	0.0183	CbGeAlD
Tolbutamide—Eruption—Gemcitabine—kidney cancer	0.00325	0.0212	CcSEcCtD
Tolbutamide—ABCC8—kidney—kidney cancer	0.00323	0.0177	CbGeAlD
Tolbutamide—SLC15A1—renal system—kidney cancer	0.00319	0.0175	CbGeAlD
Tolbutamide—SLC15A1—kidney—kidney cancer	0.00309	0.0169	CbGeAlD
Tolbutamide—Gliclazide—VEGFA—kidney cancer	0.00289	0.563	CrCbGaD
Tolbutamide—Hyponatraemia—Pazopanib—kidney cancer	0.00275	0.018	CcSEcCtD
Tolbutamide—SLCO2B1—renal system—kidney cancer	0.00261	0.0143	CbGeAlD
Tolbutamide—Abdominal distension—Temsirolimus—kidney cancer	0.00253	0.0165	CcSEcCtD
Tolbutamide—SLCO2B1—kidney—kidney cancer	0.00253	0.0139	CbGeAlD
Tolbutamide—SLCO1A2—renal system—kidney cancer	0.0024	0.0132	CbGeAlD
Tolbutamide—Abdominal distension—Pazopanib—kidney cancer	0.00238	0.0156	CcSEcCtD
Tolbutamide—SLCO1A2—kidney—kidney cancer	0.00232	0.0128	CbGeAlD
Tolbutamide—Haemolytic anaemia—Erlotinib—kidney cancer	0.00231	0.0151	CcSEcCtD
Tolbutamide—Hypoglycaemia—Everolimus—kidney cancer	0.00222	0.0145	CcSEcCtD
Tolbutamide—Aplastic anaemia—Dactinomycin—kidney cancer	0.00221	0.0145	CcSEcCtD
Tolbutamide—SLC15A2—nephron tubule—kidney cancer	0.00219	0.0121	CbGeAlD
Tolbutamide—Hyponatraemia—Everolimus—kidney cancer	0.00217	0.0142	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Pazopanib—kidney cancer	0.00216	0.0141	CcSEcCtD
Tolbutamide—SLC15A2—renal system—kidney cancer	0.002	0.011	CbGeAlD
Tolbutamide—SLC15A2—kidney—kidney cancer	0.00193	0.0106	CbGeAlD
Tolbutamide—Hyponatraemia—Sorafenib—kidney cancer	0.00189	0.0123	CcSEcCtD
Tolbutamide—Abdominal distension—Everolimus—kidney cancer	0.00188	0.0123	CcSEcCtD
Tolbutamide—SLC15A2—cortex of kidney—kidney cancer	0.00188	0.0103	CbGeAlD
Tolbutamide—Hypoglycaemia—Sunitinib—kidney cancer	0.00185	0.0121	CcSEcCtD
Tolbutamide—Hyponatraemia—Sunitinib—kidney cancer	0.00181	0.0119	CcSEcCtD
Tolbutamide—Pancytopenia—Vinblastine—kidney cancer	0.00178	0.0116	CcSEcCtD
Tolbutamide—Pancytopenia—Everolimus—kidney cancer	0.00178	0.0116	CcSEcCtD
Tolbutamide—Erythema—Temsirolimus—kidney cancer	0.00175	0.0114	CcSEcCtD
Tolbutamide—CYP2C8—renal system—kidney cancer	0.00168	0.00922	CbGeAlD
Tolbutamide—Erythema—Pazopanib—kidney cancer	0.00165	0.0108	CcSEcCtD
Tolbutamide—CYP2C8—kidney—kidney cancer	0.00162	0.00892	CbGeAlD
Tolbutamide—Abdominal distension—Sunitinib—kidney cancer	0.00157	0.0103	CcSEcCtD
Tolbutamide—Leukopenia—Temsirolimus—kidney cancer	0.00157	0.0102	CcSEcCtD
Tolbutamide—Agranulocytosis—Vinblastine—kidney cancer	0.00156	0.0102	CcSEcCtD
Tolbutamide—Hyponatraemia—Vincristine—kidney cancer	0.00153	0.01	CcSEcCtD
Tolbutamide—Pancytopenia—Sunitinib—kidney cancer	0.00148	0.00969	CcSEcCtD
Tolbutamide—Leukopenia—Pazopanib—kidney cancer	0.00148	0.00965	CcSEcCtD
Tolbutamide—Eruption—Doxorubicin—kidney cancer	0.00144	0.0094	CcSEcCtD
Tolbutamide—Pancytopenia—Dactinomycin—kidney cancer	0.0014	0.00917	CcSEcCtD
Tolbutamide—Thrombocytopenia—Temsirolimus—kidney cancer	0.0014	0.00914	CcSEcCtD
Tolbutamide—Thrombocytopenia—Pazopanib—kidney cancer	0.00132	0.00862	CcSEcCtD
Tolbutamide—Erythema—Everolimus—kidney cancer	0.0013	0.00851	CcSEcCtD
Tolbutamide—Erythema—Erlotinib—kidney cancer	0.00126	0.00821	CcSEcCtD
Tolbutamide—Pancytopenia—Vincristine—kidney cancer	0.00125	0.0082	CcSEcCtD
Tolbutamide—Hypoglycaemia—Paclitaxel—kidney cancer	0.00124	0.00813	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00123	0.00806	CcSEcCtD
Tolbutamide—Agranulocytosis—Dactinomycin—kidney cancer	0.00123	0.00804	CcSEcCtD
Tolbutamide—Hyponatraemia—Paclitaxel—kidney cancer	0.00122	0.00796	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Vincristine—kidney cancer	0.00121	0.00788	CcSEcCtD
Tolbutamide—Pancytopenia—Gemcitabine—kidney cancer	0.00119	0.00778	CcSEcCtD
Tolbutamide—Chlorpropamide—PTGS1—kidney cancer	0.00119	0.231	CrCbGaD
Tolbutamide—Dyspepsia—Pazopanib—kidney cancer	0.00119	0.00775	CcSEcCtD
Tolbutamide—Leukopenia—Vinblastine—kidney cancer	0.00117	0.00765	CcSEcCtD
Tolbutamide—Leukopenia—Everolimus—kidney cancer	0.00117	0.00762	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00116	0.0076	CcSEcCtD
Tolbutamide—Erythema—Sorafenib—kidney cancer	0.00113	0.00739	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Capecitabine—kidney cancer	0.0011	0.00721	CcSEcCtD
Tolbutamide—Erythema—Sunitinib—kidney cancer	0.00109	0.00711	CcSEcCtD
Tolbutamide—Abdominal distension—Paclitaxel—kidney cancer	0.00106	0.0069	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vinblastine—kidney cancer	0.00104	0.00683	CcSEcCtD
Tolbutamide—Agranulocytosis—Gemcitabine—kidney cancer	0.00104	0.00681	CcSEcCtD
Tolbutamide—Thrombocytopenia—Everolimus—kidney cancer	0.00104	0.0068	CcSEcCtD
Tolbutamide—Erythema—Dactinomycin—kidney cancer	0.00103	0.00673	CcSEcCtD
Tolbutamide—Leukopenia—Sorafenib—kidney cancer	0.00101	0.00661	CcSEcCtD
Tolbutamide—Pruritus—Temsirolimus—kidney cancer	0.00101	0.00661	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00101	0.00658	CcSEcCtD
Tolbutamide—Thrombocytopenia—Erlotinib—kidney cancer	0.001	0.00656	CcSEcCtD
Tolbutamide—Hyponatraemia—Capecitabine—kidney cancer	0.001	0.00654	CcSEcCtD
Tolbutamide—Pancytopenia—Paclitaxel—kidney cancer	0.000996	0.00651	CcSEcCtD
Tolbutamide—Leukopenia—Sunitinib—kidney cancer	0.000974	0.00636	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000957	0.00626	CcSEcCtD
Tolbutamide—Pruritus—Pazopanib—kidney cancer	0.000953	0.00623	CcSEcCtD
Tolbutamide—Dyspepsia—Everolimus—kidney cancer	0.000936	0.00612	CcSEcCtD
Tolbutamide—Leukopenia—Dactinomycin—kidney cancer	0.000922	0.00603	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Everolimus—kidney cancer	0.000918	0.006	CcSEcCtD
Tolbutamide—Thrombocytopenia—Sorafenib—kidney cancer	0.000904	0.0059	CcSEcCtD
Tolbutamide—Dyspepsia—Erlotinib—kidney cancer	0.000903	0.0059	CcSEcCtD
Tolbutamide—Rash—Temsirolimus—kidney cancer	0.000901	0.00589	CcSEcCtD
Tolbutamide—Headache—Temsirolimus—kidney cancer	0.000895	0.00585	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000886	0.00579	CcSEcCtD
Tolbutamide—Erythema—Gemcitabine—kidney cancer	0.000873	0.00571	CcSEcCtD
Tolbutamide—Thrombocytopenia—Sunitinib—kidney cancer	0.000869	0.00568	CcSEcCtD
Tolbutamide—Abdominal distension—Capecitabine—kidney cancer	0.000867	0.00566	CcSEcCtD
Tolbutamide—Rash—Pazopanib—kidney cancer	0.000849	0.00555	CcSEcCtD
Tolbutamide—Nausea—Temsirolimus—kidney cancer	0.000849	0.00555	CcSEcCtD
Tolbutamide—Headache—Pazopanib—kidney cancer	0.000843	0.00551	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—kidney cancer	0.00083	0.00543	CcSEcCtD
Tolbutamide—Leukopenia—Vincristine—kidney cancer	0.000824	0.00538	CcSEcCtD
Tolbutamide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000823	0.00538	CcSEcCtD
Tolbutamide—Pancytopenia—Capecitabine—kidney cancer	0.000818	0.00534	CcSEcCtD
Tolbutamide—Dyspepsia—Sorafenib—kidney cancer	0.000812	0.00531	CcSEcCtD
Tolbutamide—Nausea—Pazopanib—kidney cancer	0.0008	0.00523	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000797	0.00521	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Capecitabine—kidney cancer	0.000786	0.00514	CcSEcCtD
Tolbutamide—Dyspepsia—Sunitinib—kidney cancer	0.000782	0.00511	CcSEcCtD
Tolbutamide—Leukopenia—Gemcitabine—kidney cancer	0.000781	0.00511	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000767	0.00501	CcSEcCtD
Tolbutamide—Pruritus—Everolimus—kidney cancer	0.000752	0.00492	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vincristine—kidney cancer	0.000735	0.00481	CcSEcCtD
Tolbutamide—Urticaria—Sorafenib—kidney cancer	0.000733	0.00479	CcSEcCtD
Tolbutamide—Erythema—Paclitaxel—kidney cancer	0.000731	0.00478	CcSEcCtD
Tolbutamide—Pruritus—Erlotinib—kidney cancer	0.000726	0.00474	CcSEcCtD
Tolbutamide—Agranulocytosis—Capecitabine—kidney cancer	0.000716	0.00468	CcSEcCtD
Tolbutamide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000698	0.00456	CcSEcCtD
Tolbutamide—Rash—Everolimus—kidney cancer	0.00067	0.00438	CcSEcCtD
Tolbutamide—Headache—Vinblastine—kidney cancer	0.000669	0.00437	CcSEcCtD
Tolbutamide—Headache—Everolimus—kidney cancer	0.000666	0.00435	CcSEcCtD
Tolbutamide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000658	0.0043	CcSEcCtD
Tolbutamide—Leukopenia—Paclitaxel—kidney cancer	0.000654	0.00428	CcSEcCtD
Tolbutamide—Pruritus—Sorafenib—kidney cancer	0.000653	0.00427	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000648	0.00424	CcSEcCtD
Tolbutamide—Rash—Erlotinib—kidney cancer	0.000647	0.00423	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—kidney cancer	0.000645	0.00421	CcSEcCtD
Tolbutamide—Headache—Erlotinib—kidney cancer	0.000643	0.0042	CcSEcCtD
Tolbutamide—Nausea—Vinblastine—kidney cancer	0.000634	0.00414	CcSEcCtD
Tolbutamide—Nausea—Everolimus—kidney cancer	0.000631	0.00413	CcSEcCtD
Tolbutamide—Pruritus—Sunitinib—kidney cancer	0.000628	0.00411	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000615	0.00402	CcSEcCtD
Tolbutamide—Nausea—Erlotinib—kidney cancer	0.000609	0.00398	CcSEcCtD
Tolbutamide—Erythema—Capecitabine—kidney cancer	0.0006	0.00392	CcSEcCtD
Tolbutamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000584	0.00382	CcSEcCtD
Tolbutamide—Rash—Sorafenib—kidney cancer	0.000582	0.0038	CcSEcCtD
Tolbutamide—Headache—Sorafenib—kidney cancer	0.000578	0.00378	CcSEcCtD
Tolbutamide—Chlorpropamide—ABCB1—kidney cancer	0.000576	0.112	CrCbGaD
Tolbutamide—Rash—Sunitinib—kidney cancer	0.00056	0.00366	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—kidney cancer	0.000559	0.00365	CcSEcCtD
Tolbutamide—Headache—Sunitinib—kidney cancer	0.000556	0.00364	CcSEcCtD
Tolbutamide—Nausea—Sorafenib—kidney cancer	0.000548	0.00358	CcSEcCtD
Tolbutamide—Leukopenia—Capecitabine—kidney cancer	0.000537	0.00351	CcSEcCtD
Tolbutamide—Rash—Dactinomycin—kidney cancer	0.00053	0.00346	CcSEcCtD
Tolbutamide—Nausea—Sunitinib—kidney cancer	0.000527	0.00345	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—kidney cancer	0.000527	0.00344	CcSEcCtD
Tolbutamide—Dyspepsia—Paclitaxel—kidney cancer	0.000525	0.00343	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000515	0.00337	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000507	0.00331	CcSEcCtD
Tolbutamide—Pruritus—Gemcitabine—kidney cancer	0.000504	0.00329	CcSEcCtD
Tolbutamide—Nausea—Dactinomycin—kidney cancer	0.000499	0.00326	CcSEcCtD
Tolbutamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000479	0.00313	CcSEcCtD
Tolbutamide—Probenecid—ABCB1—kidney cancer	0.000476	0.0929	CrCbGaD
Tolbutamide—Urticaria—Paclitaxel—kidney cancer	0.000474	0.0031	CcSEcCtD
Tolbutamide—Rash—Vincristine—kidney cancer	0.000474	0.00309	CcSEcCtD
Tolbutamide—Headache—Vincristine—kidney cancer	0.000471	0.00307	CcSEcCtD
Tolbutamide—Agranulocytosis—Doxorubicin—kidney cancer	0.000462	0.00302	CcSEcCtD
Tolbutamide—Rash—Gemcitabine—kidney cancer	0.000449	0.00294	CcSEcCtD
Tolbutamide—Headache—Gemcitabine—kidney cancer	0.000446	0.00292	CcSEcCtD
Tolbutamide—Nausea—Vincristine—kidney cancer	0.000446	0.00292	CcSEcCtD
Tolbutamide—Dyspepsia—Capecitabine—kidney cancer	0.000431	0.00282	CcSEcCtD
Tolbutamide—Nausea—Gemcitabine—kidney cancer	0.000423	0.00277	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000423	0.00276	CcSEcCtD
Tolbutamide—Pruritus—Paclitaxel—kidney cancer	0.000422	0.00276	CcSEcCtD
Tolbutamide—Urticaria—Capecitabine—kidney cancer	0.000389	0.00254	CcSEcCtD
Tolbutamide—Erythema—Doxorubicin—kidney cancer	0.000387	0.00253	CcSEcCtD
Tolbutamide—Rash—Paclitaxel—kidney cancer	0.000376	0.00246	CcSEcCtD
Tolbutamide—Headache—Paclitaxel—kidney cancer	0.000374	0.00244	CcSEcCtD
Tolbutamide—Nausea—Paclitaxel—kidney cancer	0.000354	0.00232	CcSEcCtD
Tolbutamide—Pruritus—Capecitabine—kidney cancer	0.000346	0.00226	CcSEcCtD
Tolbutamide—Leukopenia—Doxorubicin—kidney cancer	0.000346	0.00226	CcSEcCtD
Tolbutamide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000309	0.00202	CcSEcCtD
Tolbutamide—Rash—Capecitabine—kidney cancer	0.000309	0.00202	CcSEcCtD
Tolbutamide—Headache—Capecitabine—kidney cancer	0.000307	0.002	CcSEcCtD
Tolbutamide—Nausea—Capecitabine—kidney cancer	0.000291	0.0019	CcSEcCtD
Tolbutamide—Dyspepsia—Doxorubicin—kidney cancer	0.000278	0.00182	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000272	0.00178	CcSEcCtD
Tolbutamide—Urticaria—Doxorubicin—kidney cancer	0.000251	0.00164	CcSEcCtD
Tolbutamide—Pruritus—Doxorubicin—kidney cancer	0.000223	0.00146	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—kidney cancer	0.000199	0.0013	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—kidney cancer	0.000198	0.00129	CcSEcCtD
Tolbutamide—Nausea—Doxorubicin—kidney cancer	0.000187	0.00122	CcSEcCtD
Tolbutamide—CYP2C8—Biological oxidations—GSTM1—kidney cancer	5.74e-05	0.00103	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	5.66e-05	0.00102	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CRABP1—kidney cancer	5.61e-05	0.00101	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALAD—kidney cancer	5.6e-05	0.001	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTP1—kidney cancer	5.58e-05	0.001	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.57e-05	0.000998	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.57e-05	0.000998	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	5.5e-05	0.000986	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ST3GAL2—kidney cancer	5.46e-05	0.00098	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	5.45e-05	0.000976	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CRABP1—kidney cancer	5.44e-05	0.000975	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.42e-05	0.000972	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	5.37e-05	0.000963	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALDH1A1—kidney cancer	5.34e-05	0.000957	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.23e-05	0.000938	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ITPR2—kidney cancer	5.21e-05	0.000935	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CA9—kidney cancer	5.14e-05	0.000921	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTM1—kidney cancer	5.13e-05	0.000919	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PGK1—kidney cancer	5.12e-05	0.000918	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC5A3—kidney cancer	5.12e-05	0.000918	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	5.09e-05	0.000912	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ITPR2—kidney cancer	5.06e-05	0.000907	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	5.06e-05	0.000907	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—LDHB—kidney cancer	5.02e-05	0.0009	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	5.02e-05	0.000899	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	4.86e-05	0.000871	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—MAPK1—kidney cancer	4.81e-05	0.000862	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	4.79e-05	0.000859	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ACY1—kidney cancer	4.79e-05	0.000859	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTT1—kidney cancer	4.76e-05	0.000853	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ACHE—kidney cancer	4.76e-05	0.000853	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	4.67e-05	0.000838	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—MAPK1—kidney cancer	4.66e-05	0.000836	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTT1—kidney cancer	4.61e-05	0.000827	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ACHE—kidney cancer	4.61e-05	0.000827	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	4.61e-05	0.000827	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SCARB1—kidney cancer	4.5e-05	0.000807	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS1—kidney cancer	4.46e-05	0.000799	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	4.43e-05	0.000795	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.4e-05	0.000788	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	4.37e-05	0.000784	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PSMD7—kidney cancer	4.37e-05	0.000783	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CRABP1—kidney cancer	4.37e-05	0.000783	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SCARB1—kidney cancer	4.37e-05	0.000783	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CA9—kidney cancer	4.35e-05	0.000781	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS1—kidney cancer	4.32e-05	0.000775	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ACY1—kidney cancer	4.28e-05	0.000766	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.26e-05	0.000763	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PSMD7—kidney cancer	4.24e-05	0.00076	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—BCHE—kidney cancer	4.14e-05	0.000743	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.13e-05	0.000741	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC5A5—kidney cancer	4.09e-05	0.000734	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.08e-05	0.000732	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PDHB—kidney cancer	4.07e-05	0.00073	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ITPR2—kidney cancer	4.06e-05	0.000728	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—POMC—kidney cancer	4.06e-05	0.000728	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.05e-05	0.000727	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—BCHE—kidney cancer	4.02e-05	0.00072	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC5A5—kidney cancer	3.97e-05	0.000711	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC2A1—kidney cancer	3.95e-05	0.000709	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ACY1—kidney cancer	3.9e-05	0.000699	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC2A1—kidney cancer	3.83e-05	0.000687	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CCBL1—kidney cancer	3.83e-05	0.000686	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—RAF1—kidney cancer	3.77e-05	0.000676	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTT1—kidney cancer	3.7e-05	0.000664	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ACHE—kidney cancer	3.7e-05	0.000664	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CRABP1—kidney cancer	3.7e-05	0.000664	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.65e-05	0.000654	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PDHB—kidney cancer	3.64e-05	0.000652	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—POMC—kidney cancer	3.62e-05	0.00065	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SCARB1—kidney cancer	3.51e-05	0.000629	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS1—kidney cancer	3.47e-05	0.000622	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.46e-05	0.000621	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ITPR2—kidney cancer	3.44e-05	0.000617	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CCBL1—kidney cancer	3.42e-05	0.000613	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PSMD7—kidney cancer	3.4e-05	0.00061	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.39e-05	0.000608	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.32e-05	0.000596	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GLIPR1—kidney cancer	3.32e-05	0.000595	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPAT—kidney cancer	3.32e-05	0.000595	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PDHB—kidney cancer	3.31e-05	0.000594	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—POMC—kidney cancer	3.3e-05	0.000592	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTP1—kidney cancer	3.3e-05	0.000591	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.28e-05	0.000588	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.24e-05	0.000582	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—BCHE—kidney cancer	3.23e-05	0.000579	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTP1—kidney cancer	3.2e-05	0.000573	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC5A5—kidney cancer	3.19e-05	0.000572	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.17e-05	0.000569	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.15e-05	0.000565	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ACHE—kidney cancer	3.14e-05	0.000563	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTT1—kidney cancer	3.14e-05	0.000563	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ABCB1—kidney cancer	3.12e-05	0.000559	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CCBL1—kidney cancer	3.12e-05	0.000559	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.09e-05	0.000554	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—FH—kidney cancer	3.09e-05	0.000553	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APRT—kidney cancer	3.09e-05	0.000553	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC2A1—kidney cancer	3.08e-05	0.000552	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTM1—kidney cancer	3.03e-05	0.000543	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ABCB1—kidney cancer	3.03e-05	0.000542	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.02e-05	0.000541	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SCARB1—kidney cancer	2.97e-05	0.000533	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.96e-05	0.000531	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPAT—kidney cancer	2.96e-05	0.000531	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS1—kidney cancer	2.94e-05	0.000527	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTM1—kidney cancer	2.94e-05	0.000527	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.93e-05	0.000525	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GPC3—kidney cancer	2.9e-05	0.00052	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.9e-05	0.000519	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PSMD7—kidney cancer	2.88e-05	0.000517	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP1A1—kidney cancer	2.87e-05	0.000515	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CA2—kidney cancer	2.82e-05	0.000506	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.82e-05	0.000505	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP1A1—kidney cancer	2.78e-05	0.000499	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—FH—kidney cancer	2.75e-05	0.000494	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APRT—kidney cancer	2.75e-05	0.000494	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALAD—kidney cancer	2.75e-05	0.000493	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—BCHE—kidney cancer	2.73e-05	0.00049	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPAT—kidney cancer	2.7e-05	0.000484	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.7e-05	0.000484	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC5A5—kidney cancer	2.7e-05	0.000484	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.69e-05	0.000483	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.68e-05	0.000481	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.67e-05	0.000478	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.64e-05	0.000473	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.62e-05	0.00047	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC2A1—kidney cancer	2.61e-05	0.000468	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GPC3—kidney cancer	2.59e-05	0.000464	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTP1—kidney cancer	2.57e-05	0.00046	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.53e-05	0.000454	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CA2—kidney cancer	2.52e-05	0.000452	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.52e-05	0.000451	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PGK1—kidney cancer	2.52e-05	0.000451	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APRT—kidney cancer	2.51e-05	0.00045	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—FH—kidney cancer	2.51e-05	0.00045	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.49e-05	0.000446	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LDHB—kidney cancer	2.47e-05	0.000442	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALAD—kidney cancer	2.46e-05	0.00044	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.46e-05	0.00044	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ABCB1—kidney cancer	2.43e-05	0.000436	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.4e-05	0.00043	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GPC3—kidney cancer	2.36e-05	0.000423	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTM1—kidney cancer	2.36e-05	0.000423	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.34e-05	0.00042	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.34e-05	0.000419	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CA2—kidney cancer	2.3e-05	0.000412	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PGK1—kidney cancer	2.25e-05	0.000403	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.25e-05	0.000403	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALAD—kidney cancer	2.24e-05	0.000401	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP1A1—kidney cancer	2.24e-05	0.000401	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.21e-05	0.000396	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LDHB—kidney cancer	2.2e-05	0.000395	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.19e-05	0.000392	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTP1—kidney cancer	2.18e-05	0.00039	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—POMC—kidney cancer	2.14e-05	0.000384	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CA9—kidney cancer	2.14e-05	0.000384	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.14e-05	0.000383	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.09e-05	0.000375	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—POMC—kidney cancer	2.08e-05	0.000372	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ABCB1—kidney cancer	2.06e-05	0.000369	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PGK1—kidney cancer	2.05e-05	0.000367	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.05e-05	0.000367	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LDHB—kidney cancer	2.01e-05	0.00036	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTM1—kidney cancer	2e-05	0.000358	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CA9—kidney cancer	1.91e-05	0.000342	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.9e-05	0.00034	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.87e-05	0.000335	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CRABP1—kidney cancer	1.82e-05	0.000326	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CA9—kidney cancer	1.74e-05	0.000312	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—kidney cancer	1.71e-05	0.000306	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.7e-05	0.000305	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ITPR2—kidney cancer	1.69e-05	0.000303	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—POMC—kidney cancer	1.67e-05	0.000299	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000297	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CRABP1—kidney cancer	1.62e-05	0.000291	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.56e-05	0.000279	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.56e-05	0.000279	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTT1—kidney cancer	1.54e-05	0.000276	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ACHE—kidney cancer	1.54e-05	0.000276	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ITPR2—kidney cancer	1.51e-05	0.000271	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTEN—kidney cancer	1.49e-05	0.000267	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CRABP1—kidney cancer	1.48e-05	0.000265	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SCARB1—kidney cancer	1.46e-05	0.000262	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS1—kidney cancer	1.45e-05	0.000259	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTEN—kidney cancer	1.44e-05	0.000259	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PSMD7—kidney cancer	1.42e-05	0.000254	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—POMC—kidney cancer	1.41e-05	0.000253	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.39e-05	0.000249	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ACHE—kidney cancer	1.38e-05	0.000247	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTT1—kidney cancer	1.38e-05	0.000247	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ITPR2—kidney cancer	1.38e-05	0.000247	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—BCHE—kidney cancer	1.34e-05	0.000241	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—kidney cancer	1.33e-05	0.000239	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.33e-05	0.000238	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SCARB1—kidney cancer	1.3e-05	0.000234	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS1—kidney cancer	1.29e-05	0.000231	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.00023	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.27e-05	0.000227	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PSMD7—kidney cancer	1.26e-05	0.000227	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTT1—kidney cancer	1.26e-05	0.000225	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ACHE—kidney cancer	1.26e-05	0.000225	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.24e-05	0.000223	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—BCHE—kidney cancer	1.2e-05	0.000215	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SCARB1—kidney cancer	1.19e-05	0.000213	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.18e-05	0.000212	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS1—kidney cancer	1.18e-05	0.000211	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTEN—kidney cancer	1.16e-05	0.000208	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PSMD7—kidney cancer	1.15e-05	0.000207	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.14e-05	0.000205	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—kidney cancer	1.13e-05	0.000202	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.11e-05	0.000199	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—BCHE—kidney cancer	1.09e-05	0.000196	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.08e-05	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.08e-05	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000192	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CA—kidney cancer	1.05e-05	0.000188	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.04e-05	0.000187	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CA—kidney cancer	1.02e-05	0.000183	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.01e-05	0.000181	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ABCB1—kidney cancer	1.01e-05	0.000181	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTEN—kidney cancer	9.83e-06	0.000176	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTM1—kidney cancer	9.82e-06	0.000176	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.68e-06	0.000174	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTP1—kidney cancer	9.54e-06	0.000171	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.31e-06	0.000167	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCB1—kidney cancer	9.03e-06	0.000162	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.83e-06	0.000158	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTM1—kidney cancer	8.77e-06	0.000157	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTP1—kidney cancer	8.7e-06	0.000156	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	8.31e-06	0.000149	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCB1—kidney cancer	8.23e-06	0.000148	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CA—kidney cancer	8.19e-06	0.000147	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTM1—kidney cancer	7.99e-06	0.000143	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.65e-06	0.000137	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.58e-06	0.000136	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—POMC—kidney cancer	6.94e-06	0.000124	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CA—kidney cancer	6.93e-06	0.000124	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.83e-06	0.000122	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.23e-06	0.000112	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—POMC—kidney cancer	6.2e-06	0.000111	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—POMC—kidney cancer	5.65e-06	0.000101	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—kidney cancer	5.54e-06	9.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—kidney cancer	4.94e-06	8.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTEN—kidney cancer	4.83e-06	8.66e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—kidney cancer	4.51e-06	8.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTEN—kidney cancer	4.31e-06	7.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTEN—kidney cancer	3.93e-06	7.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.41e-06	6.11e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.04e-06	5.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.77e-06	4.97e-05	CbGpPWpGaD
